Duncan Gilmour
About Duncan Gilmour
Duncan Gilmour (age 53) is Chief Financial Officer, Treasurer and Secretary of inTEST Corporation (INTT), appointed effective June 2021; he previously served as Americas Region Controller at ABB’s Process Automation Measurement & Analytics Division and held senior finance roles at Tyco, with earlier audit experience at PwC. He holds a BAcc Joint Honours in Economics and Accounting from the University of Glasgow and is a Chartered Accountant (ICAS) . During his tenure, INTT emphasizes a multi-year strategy that “more than doubled revenue” since early 2021, while total shareholder return fluctuated: stock closed at $12.72 (12/31/21), $10.30 (12/30/22), $13.60 (12/29/23), and $8.59 (12/31/24) .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| ABB, Inc. (Process Automation Measurement & Analytics) | Americas Region Controller | 2017–2021 | Senior finance leadership in industrial tech; controllership for regional P&L |
| Tyco International (Corporate) | Finance Director, Enterprise Support | 2014–2017 | Directed enterprise finance support functions |
| Tyco International (Fire Protection Products) | Finance Director, Special Hazards; Americas Finance Director; Global FP&A Director; Global Controller; Director of Compliance | 2004–2014 | Led divisional finance, FP&A, controllership, and compliance across multiple global roles |
| Coopers & Lybrand / PwC | Audit Manager; Senior Associate; Supervisor/Audit Associate | 1993–2004 | Public accounting and audit management across industries |
External Roles
No external directorships or outside public company board roles disclosed for Mr. Gilmour .
Fixed Compensation
| Component | 2023 | 2024 |
|---|---|---|
| Annual base salary ($) | 271,400 | 282,500 (effective Apr 1, 2024) |
| Target bonus (% of base) | Not disclosed | 65% (raised by 10 pts in 2024) |
| Actual annual bonus ($) | 128,843 | 45,906 (25% of target) |
Performance Compensation
2024 Short-Term Incentive (STI)
| Metric | Weight | Thresholds/Max | Actual Result | Payout Impact |
|---|---|---|---|---|
| Company revenue & Adjusted EBITDA matrix | 60% | Thresholds: 80% (revenue) / 86% (Adj. EBITDA); Max: 120% (revenue) / 114% (Adj. EBITDA) | Not achieved | 0% of weighted component |
| Average Net Working Capital (vs budget) | 20% | Max 150% of target; min performance threshold 120% of NWC target (inverse measure) | Exceeded | 125% of weighted component |
| Alfamation S.p.A. revenue & EBITDA (strategic) | 20% | Max 110% of target; min threshold 100% | Not achieved | 0% of weighted component |
| Total STI payout (as % of target) | — | — | — | 25% (paid $45,906) |
The STI financial payout grid provides scaling from 0% to 175% of target based on revenue/Adj. EBITDA achievement .
2024 Long-Term Incentives (LTI) – Granted March 6, 2024
| Award Type | Shares/Options | Grant-date Terms | Vesting |
|---|---|---|---|
| Time-vested RSAs | 7,356 | FV recognized as “Stock Awards” ($166,676 for 2024 annual awards aggregate; pro-rata expense reported) | 25% per year starting Mar 6, 2025 |
| Performance-vested RSAs (PSAs) | 7,355 | Measured on 2026 performance; proxy references Adjusted EBITDA percentage and also audited revenue vs target; vesting factor 0–150% | Cliff vesting at 3 years (target date Mar 6, 2027) subject to metric |
| Stock options | 12,724 | Exercise price $11.33; FV expensed as “Options” ($83,383 aggregate for 2024 awards) | 25% per year starting Mar 6, 2025; expiration 3/5/2034 |
Equity mix reflects Committee design using RSAs (retention), PSAs (pay-for-performance), and options (long-term value creation) .
Equity Ownership & Alignment
Beneficial Ownership (as of April 21, 2025)
| Holder | Shares Beneficially Owned | % of Class | Composition Notes |
|---|---|---|---|
| Duncan Gilmour | 86,247 | <1% | Includes 20,825 Restricted Shares; 22,792 Performance-Based Shares; 24,943 Option Shares; and 200 shares owned by spouse |
Outstanding Equity (as of Dec 31, 2024; closing price $8.59)
| Instrument | Status | Quantity | Exercise Price | Expiration | Unvested Shares | Market Value of Unvested ($) |
|---|---|---|---|---|---|---|
| Options | Exercisable | 6,078 | 16.80 | 6/13/2031 | — | — |
| Options | Unexercisable | 2,026 | 16.80 | 6/13/2031 | — | — |
| Options | Exercisable | 6,424 | 9.76 | 3/8/2032 | — | — |
| Options | Unexercisable | 6,424 | 9.76 | 3/8/2032 | — | — |
| Options | Exercisable | 2,011 | 16.06 | 3/7/2033 | — | — |
| Options | Unexercisable | 6,033 | 16.06 | 3/7/2033 | — | — |
| Options | Unexercisable | 12,724 | 11.33 | 3/5/2034 | — | — |
| RSAs/PSAs | Unvested | — | — | — | 497 | $4,269 |
| RSAs/PSAs | Unvested | — | — | — | 10,247 | $88,022 |
| RSAs/PSAs | Unvested | — | — | — | 8,174 | $70,215 |
| RSAs/PSAs | Unvested | — | — | — | 14,711 | $126,367 |
- Aggregate unvested RSAs/PSAs total 33,629 shares (market value $288,873 at $8.59) .
- All outstanding option strikes ($9.76–$16.80) were above the $8.59 year-end price, implying options were out-of-the-money as of 12/31/24, limiting near-term exercise-driven selling pressure .
Ownership Policies and Alignment
- Management ownership guidelines: CFO must hold 2x base salary in INTT stock; retain 50% of net shares until target met; as of Apr 1, 2025, CFO not yet at target due largely to share price decline, but within five-year phase-in .
- Hedging and pledging prohibited for officers and directors under insider trading policy (no margin purchases or pledging) .
- No related party transactions disclosed for executives/directors in the period .
- Section 16(a) compliance: all executive officers compliant during the prior fiscal year; one late Form 4 was for a former officer, not CFO .
Employment Terms
| Term | Disclosure |
|---|---|
| Employment agreement | At-will; offer letter dated June 10, 2021 |
| Initial base salary | $240,000 at hire (2021) |
| Additional sign-on/performance equity | One-time performance-based restricted stock with target value $100,000 (vested Aug 24, 2023 at 150%) |
| Restrictive covenants | Confidentiality, non-competition, non-solicitation; assignment of inventions; non-disparagement |
| Change-of-control (CoC) protection | Double-trigger: if terminated without Cause or resigns for Good Reason within 2 years post-CoC, receives 1 year of base salary continuation, continued benefits for 1 year, and variable performance-based compensation for that year; subject to release and 280G limitation |
| Equity acceleration | Upon CoC, death or Disability, all equity awards become 100% vested |
| Severance (non-CoC) | Not disclosed (no general severance terms in proxy) |
| Clawback | Dodd-Frank compliant policy; in 2024, Company recovered erroneously awarded pay from a covered executive (not CFO) due to restatement |
| Trading windows | Open-window trading only; event-specific blackouts possible |
Compensation Structure Analysis
- Increased at-risk pay in 2024: CFO’s target bonus raised to 65% of base (from prior year by +10 pts), aligning upside to financial, balance sheet, and strategic execution; actual payout was curtailed to 25% due to underperformance on financial and strategic components with partial offset from NWC discipline .
- LTI mix blends RSAs (retention), PSAs (2026 performance), and options (long-term value creation); PSAs reference 2026 metrics, with the proxy describing Adjusted EBITDA % and also audited revenue vs target (vest factor 0–150%), indicating a 3-year performance horizon .
- Equity award timing policy avoids opportunistic grant timing; annual grants occur on the second business day after the 10-K filing; no grants within the specified blackout window near Exchange Act reports in 2024 .
- Use of independent consultant (Radford/Aon) with no conflicts; compensation benchmarked to market medians for similarly sized tech/industrial peers via survey data .
Risk Indicators & Red Flags
- Options under water as of 12/31/24 reduce immediate monetization but could diminish motivational value if prolonged .
- Ownership guideline shortfall as of Apr 1, 2025 increases alignment pressure; however, retention requirement (50% of net shares) and phase-in reduce near-term selling .
- Company restatement triggered a clawback for a different executive; presence and enforcement of clawback policy is positive, but restatement itself is a cautionary governance data point .
- Hedging/pledging prohibited; no pledging disclosed for CFO .
Performance Compensation (Metric Detail)
| Metric | Weight | Target Definition | Threshold/Max | 2024 Actual vs Target | Payout |
|---|---|---|---|---|---|
| Company revenue & Adj. EBITDA matrix | 60% | Annual budgeted revenue and Adj. EBITDA | Threshold 80%/86%; Max 120%/114% | Below threshold | 0% |
| Average Net Working Capital | 20% | Final average NWC vs budget | Min 120% (inverse); Max 150% of target | Exceeded budget | 125% |
| Alfamation revenue & EBITDA | 20% | Year 1 prorated revenue/EBITDA targets | Min 100%; Max 110% | Below threshold | 0% |
Director/Committee and Governance Context (for compensation oversight)
- Compensation Committee (all independent): Jeffrey A. Beck (Chair), Steven J. Abrams, Gerald J. Maginnis; 4 meetings in 2024 .
- Say-on-pay on 2024 NEO compensation on ballot with Board “FOR” recommendation (annual frequency also on ballot with “ONE YEAR” recommended) .
Investment Implications
- Alignment: CFO pay structure ties significant upside to revenue/Adj. EBITDA, working capital efficiency, and strategic integration (Alfamation), with 3-year PSAs targeting 2026 performance; 2024 payout at 25% underlines downside sensitivity when targets are missed .
- Selling pressure: Near-term selling risk appears modest—options were out-of-the-money at 12/31/24 and ownership guidelines require 50% net-share retention until the 2x-salary target is met; multiple RSA tranches vest annually, but retention and policy constraints dampen immediate liquidity events .
- Retention/CoC: Double-trigger CoC with 1x salary, benefits, and one-year variable comp plus equity acceleration provides standard-market protection without tax gross-ups; non-compete and non-solicit support continuity .
- Execution risk: The Company states revenue more than doubled since early 2021, but 2024 TSR was down ~37% Y/Y; PSAs focused on 2026 performance raise stakes for multi-year execution, particularly on profitability and/or growth (as described) .
No related-party transactions disclosed; Section 16 compliance observed; hedging/pledging prohibited—overall governance posture supports shareholder alignment .